Snehal Shah
Technik-/Wissenschafts-/F&E-Leiter bei OCULIS HOLDING AG
Profil
Snehal Shah is currently the President-Research & Development at Oculis Holding AG.
Previously, Dr. Shah worked as a Member-Hisamitsu Group at Noven Pharmaceuticals, Inc. from 2012 to 2017.
Dr. Shah also held the position of SVP, Chief Regulatory & Product Strategy Officer at IVERIC bio, Inc. Dr. Shah holds a doctorate degree from the University of Kansas and an undergraduate degree from Rutgers University- Newark.
Aktive Positionen von Snehal Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| OCULIS HOLDING AG | Technik-/Wissenschafts-/F&E-Leiter | 10.04.2024 |
Ehemalige bekannte Positionen von Snehal Shah
| Unternehmen | Position | Ende |
|---|---|---|
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Corporate Officer/Principal | 01.01.2017 |
| IVERIC BIO, INC. | General Counsel | - |
Ausbildung von Snehal Shah
| Rutgers University- Newark | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OCULIS HOLDING AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
